Literature DB >> 15625619

Epstein-Barr virus-associated hemophagocytic syndrome in a patient with lupus nephritis.

Masato Isome1, Junzo Suzuki, Ai Takahashi, Hiromichi Murai, Ruriko Nozawa, Shigeo Suzuki, Yukihiko Kawasaki, Hitoshi Suzuki.   

Abstract

Hemophagocytic syndrome (HPS) is an unusual but severe illness associated with a variety of infections, as well as genetic, malignant tumors, and autoimmune diseases. We report an 11-year-old girl with systemic lupus erythematosus and nephritis who developed HPS associated with Epstein-Barr virus reactivation. In our patient, the onset of reactive HPS might be related to immunosuppressive treatment during the course of lupus nephritis.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15625619     DOI： 10.1007/s00467-004-1704-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  10 in total

1.  The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus.

Authors:  T Papo; M H Andre; Z Amoura; O Lortholary; B Tribout; L Guillevin; J C Piette
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.

Authors:  J D Lay; C J Tsao; J Y Chen; M E Kadin; I J Su
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis.

Authors:  G Janka; S Imashuku; G Elinder; M Schneider; J I Henter
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

Review 4.  Hemophagocytosis in autoimmune disease.

Authors:  I Sekigawa; J Suzuki; M Nawata; K Ikeda; M Koike; N Iida; H Hashimoto; K Oshimi
Journal:  Clin Exp Rheumatol       Date:  2001 May-Jun       Impact factor: 4.473

Review 5.  Hematophagic histiocytosis. A report of 23 new patients and a review of the literature.

Authors:  A P Reiner; J L Spivak
Journal:  Medicine (Baltimore)       Date:  1988-11       Impact factor: 1.889

6.  High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome.

Authors:  D S Gill; A Spencer; R G Cobcroft
Journal:  Br J Haematol       Date:  1994-09       Impact factor: 6.998

Review 7.  IVIG treatment of adenovirus infection-associated macrophage activation syndrome in a two-year-old boy: case report and review of the literature.

Authors:  Markus G Seidel; Ulrike Kastner; Milen Minkov; Helmut Gadner
Journal:  Pediatr Hematol Oncol       Date:  2003-09       Impact factor: 1.969

8.  Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement.

Authors:  S Imashuku; S Hibi; F Fujiwara; S Ikushima; S Todo
Journal:  Br J Haematol       Date:  1994-11       Impact factor: 6.998

9.  The acute lupus hemophagocytic syndrome.

Authors:  K F Wong; P K Hui; J K Chan; Y W Chan; S Y Ha
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

Review 10.  Hemophagocytic syndromes and infection.

Authors:  D N Fisman
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883
  10 in total
  2 in total

1.  Association of Macrophage Activating Syndrome with Castleman's Syndrome in Systemic Lupus Erythematosus.

Authors:  Shamsa Shariatpanahi; Shahryar Pourfarzam; Mohammadhosein Gheini
Journal:  Iran J Pathol       Date:  2016

Review 2.  Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review.

Authors:  Jie Qian; Cheng-De Yang
Journal:  Clin Rheumatol       Date:  2006-03-31       Impact factor: 3.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.